Complement and Toll-like receptors (TLRs) play key roles in the host immune response and are swiftly activated by infection or other types of immunological stress. This review focuses on the capacity of complement and TLRs to engage in signaling crosstalk, ostensibly to coordinate immune and inflammatory responses through synergistic or antagonistic (regulatory) interactions. However, overactivation or dysregulation of either system may lead-often synergistically-to exaggerated inflammation and host tissue injury. Intriguingly, moreover, certain pathogens can manipulate complement-TLR crosstalk pathways in ways that undermine host immunity and favor their persistence. In the setting of polymicrobial inflammatory disease, subversion of complement-TLR crosstalk by keystone pathogens can promote dysbiosis. Knowledge of the molecular mechanisms underlying complement-TLR crosstalk pathways can, therefore, be used productively for tailored therapeutic approaches, such as, to enhance host immunity, mitigate destructive inflammation, or counteract microbial subversion of the host response.
Historically established as a cascade of antimicrobial proteins in the blood, complement is now appreciated as a network of interacting fluid phase and cell surface-associated molecules (PRMs, convertases, and other proteases, regulators, and signaling receptors) that trigger, amplify, and regulate immunity and inflammation. 9 The complement cascade is triggered by distinct mechanisms (classical, lectin, or alternative) that converge at the third component (C3) and lead to the generation of effectors with diverse functions (e.g. recruitment and activation of inflammatory cells via the C3a and C5a anaphylatoxins that activate specific G-protein-coupled receptors; microbial opsonization through C3b; and direct lysis of susceptible targeted microbes by means of the C5b-9 membrane attack complex). 9 During an infection, complement and TLRs are rapidly activated to provide critical frontline defense and act as key mediators between innate and adaptive immunity. 10 Interestingly, several microbial products, including LPS (TLR4 agonist), zymosan (TLR2/6 agonist), and CpG DNA (TLR9 agonist), can activate complement in addition to initiating TLR signaling. 11, 12 Therefore, an appropriately coordinated host immune response would necessitate signaling crosstalk between TLR and complement pathways, leading to synergistic or antagonistic interactions.
Synergistic pathways can enhance the sensitivity of detection, as even individually weak stimuli can potentially combine to elicit a robust immune response. Conversely, antagonistic pathways can augment the specificity of the host response by controlling it and preventing bystander tissue damage. 13 Typical examples for these contrasting functions include the cooperation between TLR2 and the C-type lectin dectin-1 for effective antifungal immunity 14 and the homeostatic suppression of TLR-induced pro-inflammatory responses by adenosine receptors. 15, 16 This review summarizes recent literature on the biological importance of complement-TLR crosstalk pathways. Such pathways lead to diverse effects raging from reinforcement of innate immunity to exacerbation of pathologic inflammation or, conversely, regulation of unwarranted inflammation, depending on the receptors involved and the cellular context. Moreover, mechanisms that allow the interplay between complement and TLRs can be potentially exploited by certain pathogens to modulate the host response in ways that favor pathogen survival and persistence.
| REGULATION OF IMMUNE AND INFLAMMATORY RESPONSES BY COMPLEMENT-TLR COOPERATION
As alluded to above, complement and TLRs are swiftly co-activated in response to microbial infection, whereas common microbial molecules (such as LPS and CpG DNA) can act as both TLR ligands and complement activators. 9 At the cellular level, signaling crosstalk interactions between complement and TLRs have been shown in several cell types, including monocytes, macrophages, neutrophils, and dendritic cells. [17] [18] [19] [20] [21] [22] In vivo, the early innate immune response is shaped, to a large extent, by bidirectional crosstalk between the two systems.
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In perhaps the first in vivo systematic study to dissect complement-TLR crosstalk pathways, the authors employed systemic administration of different TLR ligands to mice lacking decay-accelerating factor (DAF), a major membrane-associated complement inhibitor. Complement-TLR crosstalk synergy has also been demonstrated at mucosal sites. Indeed, in the murine gingival tissue, the concomitant activation of C5aR and TLR2 by local co-injection of specific agonists (C5a and the TLR2 ligand Pam3Cys) induced significantly higher levels of TNF, IL-1β, IL-6, and IL-17A mRNA and protein than activation of each receptor alone. 26 In fact, destructive periodontal inflammation appears to depend on synergy between C5aR1 and TLR2, as mice deficient in either C5aR1 or TLR2 are essentially resistant against inflammatory bone loss in the periodontium. 27, 28 Consistently, treatment of mice subjected to experimental periodontitis with PMX-53, a C5aR1 antagonist, inhibits periodontal inflammation (TNF, IL-1β, IL-6, and IL-17) and bone loss, regardless of the presence of TLR2 (i.e. inflammatory bone loss can be effectively inhibited by blocking just one of the two crosstalking receptors).
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However, in other experimental systems, where interactions might be partially synergistic or additive, combined inhibition of complement and PRRs may be more effective than inhibition of each system alone.
For instance, in a human whole-blood model, combined inhibition of complement and CD14 was shown to be more effective in blocking E. coli-induced cytokine responses than single inhibition. 29, 30 CD14 lacks a transmembrane signaling domain but acts as a critical coreceptor of TLRs (mostly TLR4 and TLR2), 3 although it might also have TLR-independent effects that contribute to inflammation.
Another study in the human whole-blood model focused on interactions between complement and TLR9 signaling induced by CpG oligodeoxynucleotides, which are considered as vaccine adjuvants. 11 These investigators showed that complement inhibition at 
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Subsequent studies indeed showed that C5aR2 might also play
active, yet complex and poorly understood, roles in inflammation regulation including crosstalk interactions with TLRs. [37] [38] [39] [40] In the latter regard, C5aR2-deficient mice exhibited increased survival rates compared with wildtype controls after CLP-induced sepsis. 38 Rather than antagonizing C5aR1, C5aR2 synergizes with C5aR1 to cause sepsis by inducing the expression of the mobility group box 1 (HMGB1) protein. 38 Interestingly, the induction of HMGB1 by LPS and C5a, or by LPS alone, is diminished in C5aR2-deficient macrophages. This finding suggests involvement of possible C5aR2-TLR4 crosstalk in the induction of HMGB1 that appears to require mitogen-activated protein MEK1/2, JNK1/2, and PI3K. 38 Moreover, C5aR2 was shown to mice. 42 In contrast to these pro-inflammatory roles by C5aR2, other studies showed that C5aR2 interacts physically with and negatively regulates C5aR1 signaling in neutrophils and macrophages, 39, 43 thereby providing a mechanistic basis for its reported anti-inflammatory action. 36 In toto, the activities of C5aR2 appear to be dynamic and contextual depending on cell type, tissue, and disease model. 
| TLR REGULATION OF EXPRESSION OF COMPLEMENT COMPONENTS
The previous section discussed several studies showing that complement receptors (e.g. C3aR, C5aR1, and CR3) regulate TLR-dependent responses, such as those induced by LPS. 12, 21, 31, 45, 46 Reciprocally, TLR activation induces the expression of complement components, thereby potentially contributing to enhance complement activity in an inflammatory environment. [49] [50] [51] [52] For example, LPS induces robust production and release of factor B of the alternative pathway in macrophages (a major source of extrahepatic complement synthesis) through a TLR4-TRIF pathway that leads to JNK and NF-κB activation. 49 The same study showed that the double-stranded RNA analog polyI:C (a typical TLR3 agonist) also stimulates factor B production in macrophages via a JNK-and NF-κB-dependent mechanism; however, this pathway was not mediated by TLR3, suggesting the involvement of alternative receptors for polyI:C, such as the cytosolic sensors MDA-5 and RIG-I. 49 An independent study showed that polyI:C induces factor B expression also in colonic epithelial cells, albeit via a TLR3-dependent mechanism. 50 Importantly, the expression of factor B mRNA and protein is significantly enhanced in colonic biopsies of patients with ulcerative colitis and Crohn's disease as compared to healthy controls. In the latter condition, TLRs can respond to endogenous ligands released from stressed/ischemic tissues and local production of factor B (e.g. by cardiomyocytes in the context of myocardial infarction) may potentially contribute to complement-mediated injury during ischemia. 53 Intestinal ischemia/reperfusion induces the expression of factor B and C3 in the gut of wildtype but not TLR4-deficient mice, which exhibit reduced inflammation and tissue damage. 52 Administration of a complement inhibitor, CR2-Crry, during reperfusion ameliorated intestinal tissue damage in wild-type mice but did not further inhibit tissue damage in TLR4-deficient mice. 52 These findings suggest that ischemia/reperfusion-induced tissue damage in this model requires a crosstalk involving TLR4 regulation of local production of complement, which in turn amplifies TLR4-mediated inflammation.
A more recent study showed that, in addition to polyI:C and LPS, Pam3Cys activation of TLR2 (although not CpG activation of TLR9) also induces factor B production and release in macrophages and cardiac cells. 51 Moreover, induction of polymicrobial sepsis by CLP in mice was
shown to increase the levels of factor B (in serum, peritoneal cavity, heart, and other organs) in an MyD88-dependent manner, whereas genetic ablation of factor B reduced complement activation during sepsis, attenuated organ injury, and improved survival. 51 This study lends further support that factor B acts downstream of TLR activation and that bacterial sepsis is largely dependent on complement-TLR crosstalk. 
| SUBVERSION OF INNATE IMMUNITY BY PATHOGEN-INDUCED COMPLEMENT-TLR CROSSTALK
Periodontitis is a chronic inflammatory disease of the tooth-supporting tissues (periodontium) that is induced by local dysbiotic polymicrobial communities. 58 These communities form on subgingival tooth sites and appear to have evolved collective strategies that enable them to persist in an inflammatory environment. 59 A formidable challenge for these bacteria is to evade killing without resorting to immune suppression, as this would inhibit inflammation and hence limit their food supply, which is derived from inflammatory tissue breakdown. 60 This selective pressure might be responsible for the development of some highly sophisticated microbial tactics, which represent new paradigms in immune evasion and are reviewed below.
| Immune subversion by periodontal bacteria
Porphyromonas gingivalis, a low-abundance Gram-negative bacterium associated with periodontitis, was shown to exert a disproportionately high impact on the dysbiotic transformation of periodontal microbial communities, thereby behaving as a keystone pathogen.
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Specifically, P. gingivalis can subvert the innate host response in ways that alter the numbers and composition of the microbiota, that is, causing dysbiosis. 63 The overgrowth of a subset of species, including inflammophilic pathobionts, leads to destructive periodontal inflammation and bone loss.
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The manipulation of the host response by P. gingivalis is based, at least in part, on its capacity to instigate subversive crosstalk interactions between complement and TLRs. For instance, P. gingivalis can induce a C5aR1-TLR2 crosstalk in neutrophils to uncouple bacterial immune clearance from inflammation 19 ( Fig. 4A) , which creates a nutritionally favorable environment for the bacteria as they can feed off the inflammatory spoils (e.g. degraded collagen peptides (Fig. 4A ). These actions also promote the survival of bystander bacteria that are otherwise susceptible to neutrophil killing. 19 Conversely, inhibition of PI3K or any of the two crosstalking receptors, C5aR1 or TLR2, in the periodontium of P. gingivalis-colonized mice promotes the elimination of P. gingivalis, reverses the increase in total microbiota counts induced earlier by P. gingivalis colonization, and blocks periodontal inflammation. 19 Therefore, P. gingivalis manipulates neutrophils through distinct mechanisms that collectively promote the survival of the microbial community and the perpetuation of inflammation.
P. gingivalis induces a C5aR1-TLR2 crosstalk also in macrophages, which are thereby impaired for intracellular killing of this bacterium.
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However, the signaling mechanisms involved are completely different from those operating in neutrophils. In macrophages, the P. gingivalis C5aR1-TLR2 crosstalk leads to synergistic production of high and sustained levels of cAMP, which suppresses nitric oxide-dependent killing of P. gingivalis. 68 Specifically, elevation of cAMP leads to activation of protein kinase A (PKA), which inactivates glycogen synthase kinase-3β (GSK3β) and inhibits the expression of inducible nitric oxide synthase (iNOS), hence reducing the production of nitric oxide, a potent antimicrobial molecule 68 (Fig. 4B) .
The P. gingivalis-induced C5aR1-TLR2 crosstalk additionally regulates cytokine expression in macrophages. 27 Specifically, P. gingivalis selectively suppresses TLR2-induced IL-12p70 through a C5aR1-dependent mechanism involving ERK1/2 ( Fig. 1) , whereas the same C5aR1-TLR2 crosstalk upregulates the production of proinflammatory cytokines (IL-1β, IL-6, and TNF), which appear to mediate inflammatory bone loss in a murine model of experimental periodontitis. 27 Moreover, the ability of P. gingivalis to manipulate TLR2 activation via the C5a-C5aR1 pathway enables this microbe to inhibit the production of IL-12p70 and secondarily interferon (IFN)γ resulting in enhanced pathogen survival. 27 Therefore, overall, P. gingivalis appears Fig. 1) .
Similar but relatively attenuated inhibitory effects were observed after C3aR activation. 12, 69 CR3 plays many and diverse roles in immunity and inflammation, including leukocyte transmigration and iC3b-mediated phagocytosis. 71 Besides interacting with host molecules (iC3b, fibrinogen, and intercellular adhesion molecule-1 [ICAM-1]), CR3 can also interact with various microbial molecules, such as LPS, Bordetella pertussis filamentous hemagglutinin, Leishmania gp63, and P. gingivalis FimA fimbriae. [72] [73] [74] [75] [76] In this regard, P. gingivalis FimA fimbriae can induce TLR2
inside-out signaling which transactivates the high-affinity conformation and hence the ligand-binding capacity of CR3. 77, 78 The interactions of CR3 on monocytes or macrophages with P. gingivalis lead to induction of proinflammatory cytokines (TNF, IL-1β, and IL-6) 75, 79 and promotion of ICAM-1-dependent monocyte transmigration across endothelial cell monolayers. 80 Intriguingly, the aforementioned TLR2-CR3 crosstalk is exploited by P. gingivalis for a relatively safe entry and persistence in macrophages. 81 Indeed, the intracellular survival of P. gingivalis is significantly reduced in CR3-deficient The differential effects of C5aR1 in dendritic cells as compared to macrophages might be attributed to differential regulation of the cAMP response in these two leukocyte types. As outlined above for macrophages, activation of C5aR1 leads to high levels of intracellular cAMP and thus PKA activation, which is critical for inhibiting nitric oxide-dependent killing of P. gingivalis. 68 In dendritic cells, on the other hand, C5aR1 suppresses cAMP production and hence the activation of PKA. 91 C3aR-which also facilitates intracellular killing of P. gingivalis in dendritic cells 90 -similarly inhibits the cAMP-PKA pathway. 92 As both C3aR and C5aR1 activate Gαi protein-mediated signaling, it remains unclear why the same receptors have different effects on the cAMP responses in macrophages vs dendritic cells.
However, some insights could be discussed at least at a theoretical level. Following activation of Gαi, the released Giβγ subunits regulate the production of cAMP by adenylate cyclase, either positively or negatively depending upon the specific enzyme isoform. 93 The isoforms of adenylate cyclase isoforms that are positively regulated by Giβγ are different from those that are sensitive to the inhibitory action of Gαi. 93 Thus, it can be reasoned that dendritic cells and macrophages express distinct isoforms of adenylate cyclase, thus
C3aR-or C5aR-induced Gαi signaling has different effects on the regulation of the enzyme isoforms. Another cell type-specific difference is that whereas C5a inhibits P. gingivalis-induced IL-12p70 in macrophages, 27 C5a promotes P. gingivalis-induced IL-12p70 in dendritic cells. 90 The C5a-induced inhibition of IL-12p70 by P. gingivalis is mediated by ERK1/2 signaling, 27 consistent with an earlier report that C5a-induced ERK1/2 signaling inhibits enterobacterial LPS-induced IL-12p70 in macrophages. 69 Whereas C5a induces ERK1/2 signaling also in dendritic cells, 94 the ERK1/2 pathway in this cell type upregulates, rather than inhibits, IL-12p70 production. 95 Despite its ability to transactivate and bind CR3 in macrophages, P. gingivalis fails to utilize CR3 as a phagocytic receptor in dendritic cells. 90 The reason for this difference is not understood, although a study has suggested that CR3 cannot be readily transactivated in dendritic cells. 96 Therefore, C3aR, C5aR1, and CR3, mediate cell type-specific effects on how innate leukocytes handle P. gingivalis. As dendritic cells are not as potent in pathogen destruction as compared to neutrophils or macrophages, 97 it appears paradoxical that P. gingivalis can exploit complement receptors in neutrophils and macrophages more efficiently than it does in dendritic cells.
However, given the abundance of complement cleavage products in the periodontal pocket, 98 it makes sense from an evolutionary perspective that P. gingivalis developed complement-dependent evasion mechanisms against those leukocyte types that are most often encountered in its niche. Indeed, the immediate threat to P. gingivalis in its predominant niche, the periodontal pocket, is represented by neutrophils and secondarily by macrophages, which predominate in the leukocyte infiltrate of the periodontal pocket over other leukocyte types. 
| Immune subversion by other pathogens
The TLR2-CR3 crosstalk pathway may be exploited by additional 
103
In addition to CR3, gC1qR, a complement receptor for C1q, also suppresses TLR4-induced IL-12 in human monocytes 104 ( Fig. 5 ). This regulatory effect is mediated via PI3K signaling and is selective for IL-12 in that TNF, IL-6, and IL-8 are not impacted. However, this crosstalk appears to be exploited by the hepatitis C virus whose core protein acts as a ligand for gC1qR to inhibit IL-12 production and Th1 immunity 105 (Fig. 5) . The complement regulatory receptor CD46 also engages in a similar crosstalk with TLR4. Indeed, upon binding C3b dimers, CD46 inhibits LPS-induced IL-12 production in monocytes. 106 The measles virus interacts with CD46 and thereby inhibits IL-12 production and cell-mediated immunity 106 (Fig. 5) . The underlying signaling mechanism remains uncertain. However, a post-transcriptional mechanism was implicated in a study with human herpesvirus-6, which similarly uses CD46 as a cellular receptor to suppress TLR4-induced IL-12.
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| CONCLUDING REMARKS AND OUTLOOK
The literature summarized in this review reveals an intricate interplay between complement and TLRs for regulating the expression and activation of critical components of the two systems, thereby contributing to the coordination of host immune and inflammatory responses. Fig. 4) , thereby contributing to the persistence of "inflammophilic" communities of pathobionts that exacerbate polymicrobial inflammatory diseases, such as periodontitis. 19 In this context, novel and potentially effective approaches may be to interfere with the host signaling circuitry that is exploited for microbial subversion of the immune response.
Although this review has focused on innate immunity, complement-TLR interactions also impact on adaptive immunity. An important mechanism with this regard involves signaling crosstalk in antigen-presenting cells between C5aR1 and TLR4 which downregulates the expression of IL-12 family cytokines (IL-12, IL-23, and IL-27) ( Fig. 1 ) involved in the regulation of distinct T-cell subsets (Th1, Th2, and Th17). 12, 17, 69, 70, 112 The role of C5aR1 signaling in regulating T-cell immunity in co-operation with TLRs is complex and contextual, as it can lead to different outcomes depending on the maturation stage of the antigen-presenting cell 20 or the type of crosstalking TLR.
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Moreover, cell type-and species-specific differences have been noted and reviewed elsewhere. 17, [113] [114] [115] The complex-and still incompletely understood-crosstalk interactions of complement with TLRs (and other systems reviewed else- 
